This study is not accepting new patients
Expanded Access for the Treatment of Cancers With Rearranged During Transfection (RET) Activation
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study started
- Principal Investigator
- by Lyudmila Bazhenova
Description
Summary
Details
Keywords
Eligibility
Locations
Lead Scientist at UCSD
- Lyudmila Bazhenova
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
Details
- Status
- not accepting new patients
- Start Date
- Sponsor
- Loxo Oncology, Inc.
- ID
- NCT03906331
- Study Type
- Expanded Access
- Last Updated